A High Content Clonogenic Survival Drug Screen Identifies MEK Inhibitors as Potent Radiation Sensitizers for KRAS Mutant Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

A High Content Clonogenic Survival Drug Screen Identifies MEK Inhibitors as Potent Radiation Sensitizers for KRAS Mutant Non–Small-Cell Lung Cancer

Published:2014-07 Issue:7 Volume:9 Page:965-973
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Lin Steven H.,Zhang Jing,Giri Uma,Stephan Clifford,Sobieski Mary,Zhong Ling,Mason Kathy A.,Molkentine Jessica,Thames Howard D.,Yoo Stephen S.,Heymach John V.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference28 articles.

1. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410;Curran;J Natl Cancer Inst,2011

2. The concept of synthetic lethality in the context of anticancer therapy;Kaelin;Nat Rev Cancer,2005

3. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase;Bryant;Nature,2005

4. PARP inhibitors in cancer therapy: two modes of attack on the cancer cell widening the clinical applications;Drew;Drug Resist Updat,2009

5. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial;Tutt;Lancet,2010

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ClonoScreen3D – A Novel 3-Dimensional Clonogenic Screening Platform for Identification of Radiosensitizers for Glioblastoma;International Journal of Radiation Oncology*Biology*Physics;2024-09

2. ClonoScreen3D: a novel three-dimensional clonogenic screening platform for identification of radiosensitizers for glioblastoma;2023-10-04

3. High-Content and High-Throughput Clonogenic Survival Assay Using Fluorescence Barcoding;Cancers;2023-09-28

4. Recent progress of hydrogel-based local drug delivery systems for postoperative radiotherapy;Frontiers in Oncology;2023-02-13

5. A High Throughput Screen with a Clonogenic Endpoint to Identify Radiation Modulators of Cancer;Radiation Research;2022-12-29